Background: An ageing population has service planners concerned about future levels of disease which are age dependent. Predictions of mortality for colorectal, lung and breast cancers, which account for 30% of cancer cases and 40% of cancers deaths, were calculated for 2010 and 2015, based on trends in death rates and the predicted change in the demography of the Northern Ireland population.
INTRODUCTION
In Northern Ireland cancers of the colorectum, lung and breast account for 30% of all cancer cases and about 40% of cancers deaths. 1 The diagnosis, treatment and care of patients with these diseases use significant resources, so any change in numbers is particularly relevant to service planners. Projections can also identify need for health promotion initiatives to reduce risk in a population.
The predicted changes to the population structure, of increases in the proportion of older people, 2 will result in a rise in the incidence of cancer, a disease more common in older people. Disease risk factors are the other major driver for change.
In Northern Ireland, accurate cancer incidence data is available only since 1993; death information is available for a longer period. For lung cancer, the greatest cause of cancer mortality, numbers of deaths are close to incidence levels, due to poor survival rates. Deaths therefore form the basis of this analysis, which aims to identify for planners, future demands on services and highlight areas for disease prevention.
Linear and log-linear regression models have been found to be the most practical means by which relatively short-term future patterns of cancer mortality can be estimated. 4 The use of classical age-period-cohort modelling techniques may well improve the "fit" of the model (albeit at the expense of extra degrees of freedom), but the random variation associated with parameter estimates can lead to erratic projections. 5 In this study, the identification of the most recent trends was assisted through inflexion point regression analysis of the data, using the US National Cancer Institute's (NCI) "Joinpoint" program (Version 3.0), 6 a Windows-based statistical package used to analyse modelled data where several trend-lines are connected together at "joinpoints". The software takes trend www.ums.ac.uk Ulster Med J 2006; 75 (2) 120-125 www.ums.ac.uk √ data (in this case age-standardised cancer mortality rates) and fits the simplest inflexion model that the data allows. The programme starts with the minimum number of joinpoints (e.g. 0 joinpoints, which is a straight line) and tests whether more joinpoints are statistically significant and must be added to the model, thus enabling the user to test whether an apparent change in trend is statistically significant. 7 Existing incidence-based modelling tools developed by Dyba and Hakulinen from the Finnish Cancer Registry, 8, 9 were used to predict cancer mortality, on the principle that the underlying theoretical assumptions apply equally to incidence and mortality data. These assumptions are:
1. Future cancer death trends can be modelled by extrapolating a historic trend.
2. The lengths of the data time-series permit the estimation of models that take account of age-sex group specific trends.
3. The numbers of deaths in each age-sex-timeperiod stratum are Poisson distributed.
4. Where historic trends in standardized deaths are decreasing, a log-linear model is appropriate to estimate the average rate, whereas a linear model is used for increasing or constant trends to avoid explosive growth.
Let be the mortality rate for age group i in period t, given n it , the number of persons and c it the number of deaths. Let α i , ß i be the model parameters for age group i.
A description of the models applied in various scenarios is given below ( Table I) .
Model 4 is an alternative to model 3 and may be used where model 3 gives large confidence intervals for predictions or unrealistic trends in some age groups. It proves useful for the case, common in practice, where larger baseline death rates give larger trends over time and this functional form explicitly keeps the ratio between baseline rate and trend constant across age groups.
The 95% predicted confidence intervals generated in the output analysis are used to account not only for the uncertainty in the historical data but also for the randomness in the numbers of deaths themselves. Consequently the "95% prediction intervals" reported here may seem quite large.
M it c it n it =
Estimates of the parameters for each of the models were calculated using the STATA 8.0 Statistical package for Windows. 10 The Pearson goodness-of-fit test statistic was used to test the adequacy of the model and is given by:
where N is the number of age-groups and T the length of the time series. This statistic indicates the fit of the data to a Poisson distribution.
The 'deviance' is defined to be twice the difference between the maximum achievable log likelihood and the log likelihood at the maximum likelihood estimates of the regression parameters. It forms a useful basis for choosing between models when two models give a reasonable fit. A loglikelihood ratio test of the form D=D a -D b , where D a , D b are the deviances of fit of models a and b respectively, is used to choose between models. D follows a chi-square distribution, with degrees of freedom equal to the difference in degrees of freedom between models a and b, when both models describe the data well.
As the number of parameters increases, the model will inevitably improve. To enable selection of the most parsimonious model, the Akaike Information Criterion (AIC), which penalises the addition of extra parameters was used. Generally, where the log-likelihood test indicated either of two models was acceptable, the more parsimonious model was chosen.
Once the best model was chosen, 2004-based population projections based on assumptions regarding fertility, mortality and net migration, for N. Ireland 2 were applied to predict cancer deaths by gender and site (error range in brackets).
RESULTS
Joinpoint analysis of mortality rates ) revealed significant downward trends in: colorectal cancer in males and females; lung cancer in males and breast cancer in females (Fig 1) . A significant upward trend was demonstrated for female lung cancer. No change in trend was detected over the period for any site, i.e. a joinpoint model with zero joins (JP 0 ) was shown to best represent each time series. Variations in mortality rate trends across age-groups were also observed for some sites. Since the female lung cancer mortality series was the only one to demonstrate a significant increasing trend, further scrutiny of age-specific rates for this site was of particular interest, to determine which age-groups were driving this increase (see Fig 2) .
Joinpoint analysis of age-specific mortality rates for female lung cancer revealed no significant trend among females aged 0-64yrs (combined). Significant upward trends were observed within each of the other age-groups, but most notably among females aged 75-79 years [single continuous increase detected According to the principles outlined in the methods, the appropriate model was selected for each site. Table II details the models selected. All models provide a reasonable fit to the data, except for female lung cancer, where the model selected is very poor.
Colorectal cancer death rates are predicted to fall in males and females, but numbers in males may rise due to demographic pressures (see Table III ). This reflects the more marked historic decreasing trend in females, counterbalancing the pressure due to an ageing population.
Lung cancer deaths fell in males but increased in females between 1984 and 2004. The prediction follows on the trend for males so that despite demographic change, deaths from lung cancer in males do not rise. In females, however death rates (2015) are predicted to more than double, based on the 1985 level, due to a rising rate of disease and an ageing population.
Breast cancer death rates fell between 1984 and 2004, with a more rapid decline noticed after 1997. The model predicts slightly increasing deaths from breast cancer -despite decreasing age standardized death rates. This is driven by the ageing population.
DISCUSSION
Trends based on incidence are preferable to those based on deaths, as death trends are affected by changes in survival as well as changes in incidence. Also, deaths data are less rigorously checked compared to cancer incidence data. The accuracy of trend predictions however depends on the length of the time series examined and hence deaths are preferred in this instance.
Predictions based on historical data do not take into account future improvements in treatment or changes in the way health services are organised, but only extrapolate mortality patterns from a range of observations. These predictions also assume that current trends will remain unchanged in the future. As the predictions calculated here are only for up to ten years, such effects are likely to be minimal. However, the recent fall in breast cancer mortality, with documented significant survival improvements in the population studied 1 may not have been given enough weight in the model used. Deaths from breast cancer are falling rapidly due to earlier diagnosis and advances in treatment and the predicted increase in deaths may not materialise.
Generally, the models provide a very good fit to the data. However, the model of female lung cancer mortality trend is inadequate. Both male and female lung cancer predictions could be improved upon by the inclusion of information on smoking, as about 90% of lung cancers are directly attributed to tobacco, with very low levels of background disease.
11
The biggest determinant of the level of cancer in the short and long term is the pressure of an ageing population, as cancer is a disease more common in older people. While age standardised rates may decrease, due to public health initiatives, the absolute number of cases diagnosed and requiring treatment is likely to rise. Service planners must take this into consideration now, to ensure adequate service provision in the future. As tobacco is causally implicated in around a third of all cancers, 11 significant efforts made now, in tobacco control, could counterbalance the pressures due to demographic change and halt the predicted rise in cancers.
Trends in lung cancer mortality can be affected by smoking patterns 20-30 years previously, but the cessation of smoking, even well into middle age, can avoid most of the subsequent risk of lung cancer; stopping before middle age avoids more than 90% of the risk attributable to tobacco. 11 If current smokers can succeed in giving up the habit, mortality from lung cancer in the near future could be substantially reduced. 11 The recently announced environmental tobacco control legislation for N. Ireland is a welcome initiative which should reduce lung cancer mortality.
It is planned to introduce colorectal cancer screening in N. Ireland within the next ten years. This should further reduce deaths from colorectal cancer below that predicted by the model. Service planners should note that disease levels will The Ulster Medical Journal 
